Shares of Apollo Medical Holdings Inc (NASDAQ:AMEH) have been assigned an average broker rating score of 2.00 (Buy) from the one brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation.
Brokerages have set a 12-month consensus target price of $25.00 for the company, according to Zacks. Zacks has also given Apollo Medical an industry rank of 69 out of 256 based on the ratings given to its competitors.
Several research firms recently commented on AMEH. Zacks Investment Research upgraded shares of Apollo Medical from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 28th. ValuEngine upgraded shares of Apollo Medical from a “hold” rating to a “buy” rating in a research note on Friday. Finally, TheStreet upgraded shares of Apollo Medical from a “d” rating to a “c-” rating in a research note on Friday, June 28th.
In other Apollo Medical news, insider Adrian Vazquez sold 85,000 shares of the business’s stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $16.35, for a total value of $1,389,750.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Thomas S. Lam purchased 6,900 shares of the stock in a transaction on Tuesday, June 11th. The stock was acquired at an average cost of $14.64 per share, for a total transaction of $101,016.00. The disclosure for this purchase can be found here. Insiders acquired a total of 26,036 shares of company stock worth $375,418 in the last three months. Insiders own 11.83% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the business. Strs Ohio increased its holdings in Apollo Medical by 7.7% in the 2nd quarter. Strs Ohio now owns 15,400 shares of the company’s stock valued at $257,000 after buying an additional 1,100 shares during the period. Great West Life Assurance Co. Can bought a new stake in Apollo Medical in the 4th quarter valued at $99,000. SG Americas Securities LLC bought a new stake in Apollo Medical in the 1st quarter valued at $106,000. Manchester Financial Inc. increased its holdings in Apollo Medical by 18.5% in the 1st quarter. Manchester Financial Inc. now owns 92,621 shares of the company’s stock valued at $1,697,000 after buying an additional 14,453 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Apollo Medical by 154.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 32,242 shares of the company’s stock valued at $640,000 after buying an additional 19,561 shares during the period. 6.63% of the stock is currently owned by hedge funds and other institutional investors.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Read More: Understanding the different types of bonds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.